Obstetrics & Gynecology Doctors in Oak Harbor, WA Accepting Medicare

4 Obstetrics & Gynecology doctors found. Showing 1 - 4

Dr. Catherine Anne Borja, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Naval Hospital Oak Hbr, 3475 N Saratoga Street, Oak Harbor, WA 98278 Phone: 360-720-6462    Fax: 360-257-9990

Marshall Franklin Goldberg, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4388 Tea Rose Ct, Oak Harbor, WA 98277 Phone: 360-675-5888

Dr. Christina Lee Jahncke, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3475 N Saratoga St, Oak Harbor, WA 98278 Phone: 360-257-9848

Shun Hung Ling, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3475 N Saratoga St, Dept Ob/gyn, Naval Hospital, Oak Harbor, WA 98278 Phone: 360-257-9917    Fax: 360-257-9990

News Archive

Essen BioScience, Nycomed partner to develop modulators of voltage-gated ion channels

Essen BioScience Inc. - a specialty provider of cell-based assay solutions and contract research services - and Nycomed - a privately owned global pharmaceutical company headquartered in Zurich, Switzerland - are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain therapeutics.

Pelosi opts to stay House Democratic leader; GOP selects woman to House leadership team

In 2007, she became speaker -; and the first Californian to head the House -; overseeing passage of the most far-reaching healthcare overhaul since the creation of Medicare, an economic stimulus program, and the revamping of financial regulations, often with little or no Republican support. But while she -; and her Democratic majority -; ruled the House, she became a favorite Republican campaign target as evidence of what's wrong with Washington.

NaturalNano nanotubes improve targeting of circulating tumor cells: Study

NaturalNano, Inc. announced today that Dr. Michael King, a researcher at Cornell University, has published a new study demonstrating how NaturalNano nanotubes can improve targeting of circulating tumor cells (CTC's). These nanotubes, when added to the surface where cancer cells are attracted, enhance the natural rolling mechanism that Dr. King believes will allow them to be exposed to specific drugs or other therapeutic agents, or isolated for diagnostic and research purposes.

L2FU reports 100% recovery of recent study's lost clinical trial patients

Recovering unnecessarily lost patient information is now a viable reality. Lost to follow up rates in clinical research trials can range from 20- 60%. As a result, patients who drop from a clinical trial and 'go missing' can impart a major set-back in pharmaceutical research. Failure to contact patients and obtain final closure data, or bring them back into the clinical trial (if the protocol allows) results in study delays, increased patient recruitment costs, compromised study data, and in some cases an insufficient amount of information to prove the safety and efficacy of a drug.

Read more Medical News

› Verified 2 days ago